Sweet’N Low is not considered dangerous at normal consumption levels, but it comes with more caveats than most people expect. The active ingredient is saccharin, one of six artificial sweeteners approved by the FDA. It contains zero calories and doesn’t raise blood sugar directly, which is why it’s been a go-to sugar substitute for decades. The full picture, though, involves a complicated cancer scare, newer concerns about gut health, and specific groups who should avoid it.
What’s Actually in Sweet’N Low
The pink packet’s primary sweetener is saccharin, a compound discovered in the late 1800s that’s roughly 300 to 400 times sweeter than table sugar. The packet also contains dextrose (a simple sugar used as a bulking agent) and cream of tartar. Because saccharin is so intensely sweet, only a tiny amount is needed per packet, which is how the product stays essentially calorie-free.
The Cancer Scare and Why It Was Reversed
For years, Sweet’N Low carried a warning label linking saccharin to cancer. That label existed because high doses of saccharin caused bladder tumors in lab rats during studies in the 1970s. The finding was alarming enough that saccharin landed on the U.S. list of suspected carcinogens, and Congress required the warning on every product containing it.
The warning was removed in 2000, and saccharin was formally delisted as a carcinogen. The reason comes down to a biological quirk specific to rats. In male rats, saccharin reacts with calcium phosphate and certain proteins in urine to form a crystalline precipitate that physically damages the bladder lining. That damage triggers rapid cell turnover, and over time, that accelerated cell growth can become cancerous. Humans don’t produce the same urine composition, so this chain of events simply doesn’t happen in the human bladder. The International Agency for Research on Cancer reviewed the evidence in 1999 and concluded that the mechanism behind the rat tumors “is not relevant to humans because of critical interspecies differences in urine composition.” The U.S. National Toxicology Program reached the same conclusion the following year.
No large-scale human study has established a link between saccharin and cancer at normal dietary levels. That said, the cancer chapter is only one part of the safety conversation.
Effects on Blood Sugar and Insulin
One of the main reasons people reach for Sweet’N Low is to avoid the blood sugar spike that comes with regular sugar. On that front, saccharin itself delivers what it promises. A study from the American Diabetes Association tested overweight adults (ages 55 to 65, without diabetes) who consumed 240 mg of saccharin daily for three months. Insulin sensitivity didn’t budge. The researchers found no change in insulin resistance after three months of daily use, with no differences based on age or sex.
That’s reassuring for the direct metabolic question. But the indirect metabolic question, the one involving your gut, is where things get more complicated.
Gut Bacteria Changes
Research from the Weizmann Institute of Science, highlighted by the National Human Genome Research Institute, found that saccharin alters the composition of gut bacteria in ways that could affect metabolism. In mice, saccharin consumption led to elevated blood glucose levels within two hours, a result that didn’t occur with plain water, glucose, or sucrose. When the researchers gave the mice antibiotics to wipe out their gut bacteria, the difference in blood sugar response disappeared, pointing directly to the gut microbiome as the mediator.
Genome sequencing of the gut bacteria revealed major shifts in which microbial species were thriving. Some of the changes involved genes associated with metabolic pathways linked to obesity in both mice and humans. Even short-term consumption produced pronounced changes in gut bacteria composition and glucose intolerance in the animal models.
This is the kind of finding that deserves a realistic framing. Mouse studies use doses that are proportionally higher than what most people consume, and animal gut microbiomes don’t perfectly mirror human ones. But the research raises a legitimate concern: saccharin may undermine metabolic health through an indirect route that wouldn’t show up in a standard blood sugar test. The gut microbiome research is still being worked out in human populations, but it’s the strongest reason to be cautious about daily, long-term use.
How Much Is Considered Safe
The FDA sets an acceptable daily intake for saccharin at 15 mg per kilogram of body weight. For a 150-pound person, that works out to roughly 1,020 mg per day. A single packet of Sweet’N Low contains about 36 mg of saccharin, so you’d need to use around 28 packets daily to hit the upper safety limit. Most people don’t come close to that number.
The ADI represents the amount considered safe to consume every single day over a lifetime. It’s built with a wide safety margin, typically 100 times lower than the level that caused no adverse effects in animal studies. Occasional use of a packet or two in your coffee is well within the established safety window.
Pregnancy Is a Different Story
Saccharin crosses the placenta, which makes it different from some other artificial sweeteners. Brigham and Women’s Hospital, a Harvard-affiliated medical center, lists saccharin among substances not recommended during pregnancy, describing it as a “weak carcinogen that crosses the placenta.” A developing fetus clears substances from the body more slowly than an adult, so even small amounts of saccharin can linger longer in fetal tissue. If you’re pregnant, other sweetener options (or just reducing sweetener use altogether) are a simpler choice.
The Sulfa Allergy Question
Saccharin belongs to a chemical class called sulfonamides, which sometimes raises concerns for people with sulfa drug allergies. This turns out to be a non-issue. The American Academy of Allergy, Asthma & Immunology has confirmed that there is no clinically significant cross-reactivity between sulfonamide antibiotics and non-antibiotic sulfonamides like saccharin. The two share a structural feature but not the specific molecular arrangement that triggers allergic reactions. If you have a sulfa drug allergy, saccharin is not expected to cause a reaction.
Sweet’N Low vs. Other Sweeteners
Saccharin is one of six high-intensity sweeteners approved by the FDA, alongside aspartame, sucralose, acesulfame potassium, neotame, and advantame. Each has its own safety profile and taste characteristics. Saccharin has a slight metallic or bitter aftertaste that some people notice, especially at higher concentrations. This is why it’s often blended with other sweeteners in commercial products.
The gut microbiome concerns aren’t unique to saccharin. The same Weizmann Institute research found that aspartame and sucralose also altered gut bacteria in mice. So switching to a different artificial sweetener doesn’t necessarily sidestep the microbiome question. If that concern is what’s driving your search, reducing overall artificial sweetener intake, rather than swapping brands, is the more logical response.
The Bottom Line on Daily Use
At the amounts most people actually consume, Sweet’N Low is unlikely to cause cancer, spike your blood sugar, or trigger an allergic reaction. The FDA considers it safe, the cancer scare was based on a biological mechanism that doesn’t apply to humans, and direct metabolic studies in adults show no change in insulin sensitivity over months of use. The most credible concern is the effect on gut bacteria, which could influence metabolism in ways that standard safety testing wasn’t designed to catch. Occasional use in your morning coffee is a different calculation than sweetening every beverage and meal with it throughout the day. Pregnant individuals should avoid it entirely.